Epigral Q4 net profit rises 13% to Rs 87 crore

AHMEDABAD: Integrated chemical maker Epigral on Monday reported a 13% jump in net profit to Rs 87 crore for the March quarter, up from Rs 77 crore in the year-ago period. The company’s revenue from operations for the quarter also rose 20% to Rs 631 crore, compared to Rs 526 crore in Q4 last year.
For the full fiscal FY25, the company logged a 33% rise in revenue to a record Rs 2,565 crore. Chairman and Managing Director Maulik Patel attributed the growth to an 11% rise in overall volumes, with high-value products driving the surge. “Derivatives and

Specialty

business volume grew by around 24% in FY25, contributing 54% to revenue versus 45% in FY24,” he said.

The company also announced plans to expand its CPVC and

Epichlorohydrin

capacity, with new facilities set to go live in the first half of FY27. Founded in 2007, Epigral is India’s first manufacturer of Epichlorohydrin using 100% renewable feedstock and runs the country’s largest CPVC resin plant.